NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Wellinks

Wellinks

Private
New Haven, ConnecticutHealthcare & Life Scienceshttps://www.wellinks.com/

Last Round

Seed Round

Mar 2, 2026

Total Funding Raised

$41.57M

Company Overview

Wellinks is a digital health company that provides virtual-led cardiopulmonary care, combining remote patient monitoring technology with personalized clinical coaching to manage chronic respiratory conditions like COPD.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, Medical Devices, Health IoT, Patient Engagement, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

remote patient monitoringRPMCOPD managementvirtual carevalue-based carepredictive patient careconnected medical devicesdigital health platformclinical decision supportmedication adherencerespiratory carehospital-at-homewearable health techchronic disease managementPMPM

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Wellinks Comparables

Compare Wellinks with similar companies based on industry and business-model similarity.

Wellinks comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BreatheSuite
85%
Kivo Health
81%
ResMed
76%

Wellinks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMar 2, 2026
M&ASep 30, 2024
Series CNov 3, 2021
M&AJan 6, 2020
Series BSep 1, 2019
VC Round
Mar 7, 2018

Key People

Founding team and executive leadership

Michael Doyle

Chief Executive Officer, President And Board Member

Executive Team

Wellinks Investors

Notable investors and investment history

Wellinks investors
InvestorRounds
Connecticut InnovationsSeries C, Seed, Series A, Series B, VC Round
HighCape CapitalSeries B, Series C
Benslie Investment GroupSeries C, VC Round
Morningside VenturesSeries C
Gilde HealthcareM&A
Simon School Venture FundSeries C
Stonehenge Growth CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2025

    Partnered with CareAbout Health for COPD management.

  • Sep 30, 2024

    Gilde Healthcare participated in the M&A round.

Wellinks Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Wellinks Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Wellinks's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut
Employee Range38
Year Founded2012
Last FundingMar 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.